The therapeutic importance of herbal materials in liver diseases

• Autorzy: Rudzinska K. , Bogacz A.

Warianty tytułu

PL

Znaczenie lecznicze surowców roślinnych w chorobach wątroby

• Języki publikacji: EN

Abstrakty

EN

The liver is one of the major organs of the human body which plays an important role in the detoxification of xenobiotics, among which are mentioned alcohol, stimulants, drugs. The parenchymal cells of the liver called hepatocytes which have high ability to regenerate, are a main component of this organ. There are many factors that damage the liver e.g. drugs, chemicals, viral infections, autoimmune processes, metabolic disorders. These factors have a significant effect on the proper function of hepatocyte. In the treatment of liver diseases besides medicaments, a lot of meaning has diet as well as phytotherapy that is treatment with use of herbal preparations. The most commonly used substance is silymarin extracted from milk thistle (Silybum marianum).

PL

Wątroba jest jednym z najważniejszych narządów ludzkiego organizmu pełniącym istotną rolę w procesie detoksykacji ksenobiotyków, do których należą alkohol, używki, leki. Głównym składnikiem miąższu są komórki wątrobowe zwane hepatocytami mające dużą zdolność regeneracji. Istnieje bardzo wiele czynników uszkadzających wątrobę, np. leki, substancje chemiczne, infekcje wirusowe, procesy autoimmunologiczne, zaburzenia metaboliczne. Czynniki te w istotny sposób wpływają na prawidłową funkcję hepatocytu. W leczeniu schorzeń wątroby poza lekami współczesnej terapii istotne znaczenie ma dieta oraz fitoterapia, czyli leczenie preparatami roślinnymi. Powszechnie stosowaną substancją jest sylimaryna pozyskiwana z ostropestu plamistego (Silybum marianum).

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2012
• Tom: 58
• Numer: 1
• Opis fizyczny: p.37-46,ref.

Twórcy

autor

Rudzinska K.

• 109th Military Hospital Outpatient SPZOZ, Piotra Skargi 9-11, 70-965 Szczecin, Poland

autor

Bogacz A.

Bibliografia

• 1. Dawson PA, Shneider BL, Hofmann AF. Bile formation and enterohepatic circulation. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. Amsterdam. Elsevier, 2006:1437-1462.
• 2. Watkins PB. The role of cytochrome P450 in drug-induced liver disease. In: Kaplowitz N, DeDleve LD, eds. Drug-Induced Liver Disease. New York. Marcel Dekker, 2003:15-33.
• 3. Ghabril M, Chalasani N, Bjornsson E. Drug induced liver injury: a clinical update. Curr Opinion Gastroenterol 2010; 26:222-226.
• 4. Pelkonen O, Turpeinen M, Hakkola J, Honkakoski P, Hukkanen J, Raunio H. Inhibition and induction of human cytochrome P450 enzymes: current status. Arch Toxicol 2008; 82:667-715.
• 5. Shapiro MA, Lewis JH. Causality assessment of drug-induced hepatotoxicity: promises and pitfalls. Clin Liver Dis 2007; 11(3):477-505.
• 6. Sgro C, Clinard F, Ouazir K, Chanay H, Allard C, Guilleminet C, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002; 36(2):451-455.
• 7. Verboeket-van de Venne WP, Westerterp KR, van Holk B, Swart GR. Energy expenditur and substrate metabolizm in patiens with cirrhosis of the liver: effects of the pattern of ford intake. Gut 1995; 36:110- 116.
• 8. Strzelecka H, Kowalski J. Encyklopedia zielarstwa i ziołolecznictwa. PWN Warszawa, 2000
• 9. Karłowicz-Bodalska K, Bodalski T. Role of plant crude drugs in treatment of liver diseases. Post Fitoter 2007; 3:155-167.
• 10. Boroń-Kaczmarska A, Morańska I, Kruszewski T. Hepatic disorders, therapy recommendations. Nowa Klin 1999; 6(1):45-48.
• 11. Krauze-Baranowska M. Źródło surowca leczniczego o wielokierunkowej aktywności. Farm Pol 2004; 60:717.
• 12. Kren V, Walterova D. Silybin and silymarin - new effects and applications. Biomed Papers 2005; 149(1):29-41.
• 13. Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R. Silibinin inhibits constitutive and TNF alpha-induced activation of NF-alpha B and sensitizes human prostate carcinoma DU 145 cells to TNF alpha-induced apoptosis. Oncogene 2002; 21(11)1759-1767.
• 14. Kidd P, Head K. A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybinphosphatidylcholine complex (Siliphos). Alternat Med Rev 2005; 10(3): 193-203.
• 15. Dorai T, Aggarval BB. Role of chemopreventive agents in cancer therapy. Cancer Lett 2004; 25(2):129-140.
• 16. Singh RP, Tyangi AK, Zhao J, Agarwal R. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis. Carcinogenesis 2002; 23(3)499-510.
• 17. Zi X, Zhang J, Agarval R, Pollak M. Sylibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. Cancer Res 2000; 60:5617-5620.
• 18. Thelen P, Jarry H, Ringert RH, Wuttke W. Silybinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells. Planta Med 2004; 70:397-400.
• 19. Jiang C, Agarwal R, Lu JX. Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant silymarin; Inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells. Biochem Biophys Res Commun 2000; 276:371-378.
• 20. Gallo D, Giacomelli S, Ferlini C, Raspaglio G, Apollonio P, Prislei P, et al. Antitumor activity of the silybinphosphatidylcholine complex IdB 1016 against human ovarian cancer. Eur J Cancer 2003; 39(16):2403-2410.
• 21. Wilasrusmee C, Kittur S, Shah G, Siddigui J, Bruch D, Wilasrusmee S, et al. Immunostimulatory effect of Silybum marianum (milk thistle) extract. Med Sci Monit 2002; 8(11):BR439-443.
• 22. Krauze M. Arnika, karczoch, kozieradka w laboratorium. Panacea 2004; 2(7):32.
• 23. Gawęcki J, Hryniewiecki L. Żywienie człowieka. Podstawy nauki o żywieniu. Wydawnictwo PWN S.A., Warszawa 2004; 198-206.
• 24. Pittler MH, Thompson CO, Ernst E. Artichoke leaf extract for treating hypercholesterolemia. (Cochrane Review). In: The Cochrane Library, Issue 1, Oxford, 2006.
• 25. Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S, et al. Traditional chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther 2006; 316(3):1369-1377.
• 26. Chiu PY, Leung HY, Siu AHL, Ponn MK, Ko KM. Schisandrin B decreases the sensitivity of mitochondria to calcium ion-induced permeability transition and protects against carbon tetrachloride toxicity in mouse livers. Biol Pharm Bull 2007; 30(6):1108-1112.
• 27. Kim KH, Kim YH, Lee KR. Isolation of quinic acid derivates and flavonoids from the aerial parts of Lactuca indica L. and their hepatoprotective activity in vitro. Biorg Med Chem Lett 2007; 17(24):6739-6743.
• 28. Yuan LP, Chen FH, Ling L, Bo H, Chen ZW, Li F, et al. Protective effects of total flavonoids of Bidens bipinnata L. against carbon tetrachloride – induced liver fibrosis in Rats. J Pharm Pharmacol 2008; 60(10):1393-1402.
• 29. Koyama J, Morita I, Kobayashi N, Hirai K, Simamura E, Nobukawa T, et al. Antiallergic activity of aqueous extracts and constituents of Taxus yunnanensis. Biol Pharm Bull 2006; 29(11):2310-2312.
• 30. Krauze-Baranowska M, Skóra M. Plants as source of compounds with hepatoprotective and antiviral activity. Farm Pol 2005; 61(9):426-433.
• 31. Negi AS, Kumar JK, Lugman S, Shanker K, Gupta MM, Khanuja SP. Recent advances in plant hepatoprotectives: a chemical and biological profile of some important leads. Med Res Rev 2008; 28(5):746-772.
• 32. Panchabhai TS, Ambarkhane SV, Joshi AS, Samant BD, Rege NN. Protective effect of Tinospora codifolia, Phyllanthus emblica and their combination against antitubercular drugs induced hepatic damage: an experimental study. Phytother Res 2008; 22(5):646-650.
• 33. Zaręba S, Błoniarz J. Ocena poziomu sodu i potasu w ziołach oraz preparatach ziołowych stosowanych w terapii wątroby i dróg żółciowych. Bromatol Chem Toksykol 2008; 41:59-65.
• 34. Zając M. Nogowska M, Jedlińska A, Musialska I, Stanisz B. Biological functions of macro-and microelements. In: Vitamins and microelements. Zając M, ed. Poznan 2000, 91-152.
• 35. Suresh Kumar SV, Mishra SH. Hepatoprotective effect of Pergularia daemia (Forsk.), etanol extract and its fraction. Indian J Exp Biol 2008; 46:447-452.
• 36. Norris W, Paredes AH, Lewis JH. Drug induced liver injury in 2007. Curr Opin Gastroenterol 2008; 24(3):287-297.

Uwagi

rekord w opracowaniu